Equity Details
Price & Market Data
Price: $4.12
Daily Change: -$0.04 / 0.97%
Daily Range: $4.03 - $4.20
Market Cap: $29,581,986
Daily Volume: 85,412
Performance Metrics
1 Week: 0.25%
1 Month: -6.85%
3 Months: -3.77%
6 Months: -63.93%
1 Year: -86.92%
YTD: -42.62%
About BriaCell Therapeutics Corp. (BCTX)
Get immediate market data for BriaCell Therapeutics Corp. (BCTX). Price: 4.12, daily change: -$0.04 / 0.97%. Market cap: 29,581,986. All performance metrics at your fingertips.
Company Details
Employees: 17
Sector: Health technology
Industry: Biotechnology
Country: Canada
Details
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate the
clinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.